0
Article |

Successful Treatment of Sézary Syndrome With Lymphomatous Transformation to Large Cell Lymphoma With Fludarabine Phosphate

Anthony P. Nikko; Cynthia J. Rutherford, MD; Amit G. Pandya, MD
[+] Author Affiliations

Dallas

Department of Dermatology UT Southwestern Medical Center 5323 Harry Hines Blvd Dallas, TX 75235-9069


Arch Dermatol. 1996;132(8):978-979. doi:10.1001/archderm.1996.03890320128028
Text Size: A A A
Published online

Sézary syndrome (SS), a leukemic form of cutaneous T-cell lymphoma (CTCL), is highly resistant to contemporary therapeutic modalities. A more aggressive form of disease that is even less responsive to therapy and characterized by transformation to large cell lymphoma develops in a substantial percentage of patients with SS. We describe a patient with SS that underwent lymphomatous transformation to large cell lymphoma. Treatment with the nucleoside analogue fludarabine phosphate resulted in complete remission for 14 months.

Report of a Case.  A 72-year-old white woman sought treatment because of an 11-month history of a chronic, relapsing, intensely pruritic eruption that had progressed to a generalized erythroderma. She had been treated with topical and systemic corticosteroids, oral psoralen with UV-A, etretinate, and hydroxyurea without substantial improvement. A physical examination revealed diffuse erythema and multiple, widespread, thin, scaly plaques. Erythema and keratoderma of her palms and soles were present. Laboratory data revealed

REFERENCES

Bunn PA Jr, Hoffman SJ, Norris D, Golitz LE, Aeling JL.  Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and the Sézary syndrome) . Ann Intern Med. 1994;;121:592-602.
Wieselthier JS, Koh HK.  Sézary syndrome: diagnosis, prognosis, and critical review of treatment options . J Am Acad Dermatol. 1990;;22:381-401.
Dmitrovsky E, Matthews MJ, Bunn PA, et al.  Cytologic transformation in cutaneous T-cell lymphoma: a clinicopathologic entity associated with poor prognosis . J Clin Oncol. 1987;;5:208-215.
Greer JP, Salhany KE, Cousar JB, et al.  Clinical features associated with transformation of cerebriform T-cell lymphoma to a large cell process . Hematol Oncol. 1990;;8:215-227.
Kantarjian HM, Redman JR, Keating MJ.  Fludarabine phosphate therapy in other lymphoid malignancies . Semin Oncol. 1990;;17( (suppl 8) ):66-70.
Von Hoff DD, Dahlberg S, Hartstock RJ, Eyre HJ.  Activity of fludarabine monophosphate in patients with advanced mycosis fungoides: a Southwest Oncology Group study . J Natl Cancer Inst. 1990;;82:1353-1355.
Heald P, Rook A, Perez M, et al.  Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy . J Am Acad Dermatol. 1992;;27:427-433.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Bunn PA Jr, Hoffman SJ, Norris D, Golitz LE, Aeling JL.  Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and the Sézary syndrome) . Ann Intern Med. 1994;;121:592-602.
Wieselthier JS, Koh HK.  Sézary syndrome: diagnosis, prognosis, and critical review of treatment options . J Am Acad Dermatol. 1990;;22:381-401.
Dmitrovsky E, Matthews MJ, Bunn PA, et al.  Cytologic transformation in cutaneous T-cell lymphoma: a clinicopathologic entity associated with poor prognosis . J Clin Oncol. 1987;;5:208-215.
Greer JP, Salhany KE, Cousar JB, et al.  Clinical features associated with transformation of cerebriform T-cell lymphoma to a large cell process . Hematol Oncol. 1990;;8:215-227.
Kantarjian HM, Redman JR, Keating MJ.  Fludarabine phosphate therapy in other lymphoid malignancies . Semin Oncol. 1990;;17( (suppl 8) ):66-70.
Von Hoff DD, Dahlberg S, Hartstock RJ, Eyre HJ.  Activity of fludarabine monophosphate in patients with advanced mycosis fungoides: a Southwest Oncology Group study . J Natl Cancer Inst. 1990;;82:1353-1355.
Heald P, Rook A, Perez M, et al.  Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy . J Am Acad Dermatol. 1992;;27:427-433.

Correspondence

CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.